Solutions Revenues Total revenues for fiscal 2011 were $6.9 million in comparison to $4.9 million for fiscal 2010, an increase of $2.0 million, or 41 percent.4 million compared to $3.2 million in the prior year, an increase of $0.2 million, or 6 percent. Revenues from Translational Oncology Solutions, , known as Preclinical eValuation services previously, had been $3.5 million for 2011 as the compared to $1.7 million in the prior year, an increase of $1.8 million, or 108 percent. Costs of POS for the fiscal 12 months 2011 and 2010 were $1.6 million and $1.1 million, respectively, a rise of $0.5 million, or 44 percent.About Diabetes Diabetes affects 285 million people worldwide approximately. T2D may be the most common type, accounting for around 90 % of most diabetes instances. Diabetes is certainly a chronic disease occurring when your body either will not properly make, or make use of, the hormone insulin. On the subject of Boehringer Ingelheim The Boehringer Ingelheim group is among the world’s 20 leading pharmaceutical businesses. Headquartered in Ingelheim, Germany, it operates globally with 145 affiliates and a lot more than 42,000 employees. Because it was founded in 1885, the family-owned firm has been focused on researching, developing, manufacturing and marketing novel items of high therapeutic worth for individual and veterinary medicine.